Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disorders

Background: Sleep breathing disorders can be an additional risk factor for the development of cardiovascular disorders in patients with endocrine disorders.Aim: To assess the sleep apnea risk in patients with various endocrine disorders undergoing inpatient treatment.Materials and methods: The sleep...

Full description

Bibliographic Details
Main Authors: I. V. Misnikova, Yu. A. Kovaleva, V. A. Gubkina, N. A. Klimina
Format: Article
Language:Russian
Published: MONIKI 2019-05-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
Online Access:https://www.almclinmed.ru/jour/article/view/1037
_version_ 1818623708199124992
author I. V. Misnikova
Yu. A. Kovaleva
V. A. Gubkina
N. A. Klimina
author_facet I. V. Misnikova
Yu. A. Kovaleva
V. A. Gubkina
N. A. Klimina
author_sort I. V. Misnikova
collection DOAJ
description Background: Sleep breathing disorders can be an additional risk factor for the development of cardiovascular disorders in patients with endocrine disorders.Aim: To assess the sleep apnea risk in patients with various endocrine disorders undergoing inpatient treatment.Materials and methods: The sleep apnea risk and the severity of daytime sleepiness were evaluated in 282 inpatients with endocrine disorders based on the following questionnaires: the Epworth Sleepiness Scale (ESS), the sleep apnea screening questionnaire (SAS), and the Berlin sleep apnea risk questionnaire (BQ). To identify the real prevalence of sleep respiratory disorders in endocrine patients we performed cardio-respiratory monitoring with Watch-PAT200 (“Itamar Medical”, Israel) device in 81 patients.Results: A high sleep apnea risk according to the BQ was detected in 59.9% (160/267) of the patients, according to the SAS in 53.53% (144/269), excessive daytime sleepiness (≥ 11 points) was found in 21.66% (60/277) of the patients with the ESS. Among the patients undergoing cardiorespiratory monitoring, sleep apnea was detected in 84% (68/81), including severe apnea in 38.2% (26/68). The highest sleep apnea risk by BQ and SAS was observed in the patients with type 2 diabetes, acromegaly and hypercortisolism. Excessive daytime sleepiness by the ESS was most noticeable in those with hypercortisolism and thyrotoxicosis.Conclusion: The high risk of sleep apnea in the inpatients with type 2 diabetes mellitus, acromegaly, hypercorticism, and hypothyroidism makes it necessary to include its active screening into the algorithm of their inpatient assessment to rule out any sleep breathing disorder.
first_indexed 2024-12-16T18:45:21Z
format Article
id doaj.art-76b4947984c14b82a736173f465c0b39
institution Directory Open Access Journal
issn 2072-0505
2587-9294
language Russian
last_indexed 2024-12-16T18:45:21Z
publishDate 2019-05-01
publisher MONIKI
record_format Article
series Alʹmanah Kliničeskoj Mediciny
spelling doaj.art-76b4947984c14b82a736173f465c0b392022-12-21T22:20:51ZrusMONIKIAlʹmanah Kliničeskoj Mediciny2072-05052587-92942019-05-0147212613710.18786/2072-0505-2019-47-023626Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disordersI. V. Misnikova0Yu. A. Kovaleva1V. A. Gubkina2N. A. Klimina3Moscow Regional Research and Clinical Institute (MONIKI)Moscow Regional Research and Clinical Institute (MONIKI)Moscow Regional Research and Clinical Institute (MONIKI)Moscow Regional Research and Clinical Institute (MONIKI)Background: Sleep breathing disorders can be an additional risk factor for the development of cardiovascular disorders in patients with endocrine disorders.Aim: To assess the sleep apnea risk in patients with various endocrine disorders undergoing inpatient treatment.Materials and methods: The sleep apnea risk and the severity of daytime sleepiness were evaluated in 282 inpatients with endocrine disorders based on the following questionnaires: the Epworth Sleepiness Scale (ESS), the sleep apnea screening questionnaire (SAS), and the Berlin sleep apnea risk questionnaire (BQ). To identify the real prevalence of sleep respiratory disorders in endocrine patients we performed cardio-respiratory monitoring with Watch-PAT200 (“Itamar Medical”, Israel) device in 81 patients.Results: A high sleep apnea risk according to the BQ was detected in 59.9% (160/267) of the patients, according to the SAS in 53.53% (144/269), excessive daytime sleepiness (≥ 11 points) was found in 21.66% (60/277) of the patients with the ESS. Among the patients undergoing cardiorespiratory monitoring, sleep apnea was detected in 84% (68/81), including severe apnea in 38.2% (26/68). The highest sleep apnea risk by BQ and SAS was observed in the patients with type 2 diabetes, acromegaly and hypercortisolism. Excessive daytime sleepiness by the ESS was most noticeable in those with hypercortisolism and thyrotoxicosis.Conclusion: The high risk of sleep apnea in the inpatients with type 2 diabetes mellitus, acromegaly, hypercorticism, and hypothyroidism makes it necessary to include its active screening into the algorithm of their inpatient assessment to rule out any sleep breathing disorder.https://www.almclinmed.ru/jour/article/view/1037sleep apneaendocrine disorderrisk assessmentquestionnaire-based risk assessment
spellingShingle I. V. Misnikova
Yu. A. Kovaleva
V. A. Gubkina
N. A. Klimina
Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disorders
Alʹmanah Kliničeskoj Mediciny
sleep apnea
endocrine disorder
risk assessment
questionnaire-based risk assessment
title Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disorders
title_full Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disorders
title_fullStr Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disorders
title_full_unstemmed Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disorders
title_short Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disorders
title_sort questionnaire assessed risk of sleep apnea in inpatients with various endocrine disorders
topic sleep apnea
endocrine disorder
risk assessment
questionnaire-based risk assessment
url https://www.almclinmed.ru/jour/article/view/1037
work_keys_str_mv AT ivmisnikova questionnaireassessedriskofsleepapneaininpatientswithvariousendocrinedisorders
AT yuakovaleva questionnaireassessedriskofsleepapneaininpatientswithvariousendocrinedisorders
AT vagubkina questionnaireassessedriskofsleepapneaininpatientswithvariousendocrinedisorders
AT naklimina questionnaireassessedriskofsleepapneaininpatientswithvariousendocrinedisorders